  See all
 |
Articles: Renal/Urologic |
Prior Articles
Genitourinary Toxicity After High-Dose-Rate (HDR) Brachytherapy Combined With Hypofractionated External Beam Radiotherapy for Localized Prostate Cancer: An Analysis to Determine the Correlation Between Dose–Volume Histogram Parameters in HDR Brachytherapy and Severity of Toxicity
International Journal of Radiation Oncology*Biology*Physics, 08/31/09
Docetaxel-induced prostate cancer cell death involves concomitant activation of caspase and lysosomal pathways and is attenuated by LEDGF/p75
Molecular Cancer, 08/31/09
Free full text
Radiation Dose Predicts for Biochemical Control in Intermediate-Risk Prostate Cancer Patients Treated With Low-Dose-Rate Brachytherapy
International Journal of Radiation Oncology*Biology*Physics, 08/31/09 Efficacy of targeted therapy in patients with renal cell carcinoma with pre-existing or new bone metastases
Journal of Cancer Research & Clinical Oncology, 08/31/09 Hormonal therapy use for prostate cancer and mortality in men with coronary artery disease-induced congestive heart failure or myocardial infarction
JAMA, 08/28/09 Quality of life in patients with metastatic renal cell carcinoma: The importance of patient-reported outcomes
Cancer Treatment Reviews, 08/28/09 Non-surgical treatment of localised prostate cancer
Surgical Oncology, 08/28/09 Minimally-invasive technologies in uro-oncology: The role of cryotherapy, HIFU and photodynamic therapy in whole gland and focal therapy of localised prostate cancer
Surgical Oncology, 08/28/09 Perineural and lymphovascular invasion on prostatic biopsy: Pathological assessment and significance
Surgical Oncology, 08/28/09 The clinical significance and therapeutic implications of extraprostatic invasion
Surgical Oncology, 08/28/09 Intermittent hormone therapy and its place in the contemporary endocrine treatment of prostate cancer
Surgical Oncology, 08/28/09 Clinical significance and treatment of biochemical recurrence after definitive therapy for localized prostate cancer
Surgical Oncology, 08/28/09 Adjuvant therapy after radical prostatectomy: Clinical considerations
Surgical Oncology, 08/28/09 Indications and timing for prostate biopsy, diagnosis of early stage prostate cancer and its definitive treatment: A clinical conundrum in the PSA era
Surgical Oncology, 08/28/09 History of prostate cancer treatment
Surgical Oncology, 08/28/09 Open, laparoscopic and robotic radical prostatectomy: Optimizing the surgical approach
Surgical Oncology, 08/28/09 Regional lymph node staging in prostate cancer: Prognostic and therapeutic implications
Surgical Oncology, 08/28/09 Bilateral adrenal leiomyosarcoma treated with multiple local therapies
International Journal of Clinical Oncology, 08/27/09 The novel tumor-suppressor Mel-18 in prostate cancer: Its functional polymorphism, expression and clinical significance
International Journal of Cancer, 08/27/09 Hsp-27 expression at diagnosis predicts poor clinical outcome in prostate cancer independent of ETS-gene rearrangement
British Journal of Cancer, 08/27/09
|
|
Receive free subspecialty "5-minute updates" via email
|
|
Indexed Journals: Journal of Clinical Oncology, Cancer Research, Annals Oncology
more...
|
250 Available Pages
|
|
